Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 121

1.

[Retroperitoneal endometriosis : When a rare form of endometriosis becomes a urological disease].

Waegner RH, Schmid M, Trojan L, Ahyai SA.

Urologe A. 2016 Jun;55(6):756-62. doi: 10.1007/s00120-016-0119-0. Review. German.

PMID:
27294488
2.

See the unseen: Mesorectal lymph node metastases in prostate cancer.

Hijazi S, Meller B, Leitsmann C, Strauss A, Ritter C, Lotz J, Meller J, Trojan L, Sahlmann CO.

Prostate. 2016 Jun;76(8):776-80. doi: 10.1002/pros.23168. Epub 2016 Feb 16.

PMID:
26880517
3.

Metal telescopic and Amplatz sheath dilation in nephrolithotomy.

Hijazi S, Echtle D, Hasselhof VM, Trojan L, Heinrich E.

Urol Ann. 2016 Jan-Mar;8(1):66-9. doi: 10.4103/0974-7796.163795.

4.

Alterations in androgen deprivation enhanced prostate-specific membrane antigen (PSMA) expression in prostate cancer cells as a target for diagnostics and therapy.

Meller B, Bremmer F, Sahlmann CO, Hijazi S, Bouter C, Trojan L, Meller J, Thelen P.

EJNMMI Res. 2015 Dec;5(1):66. doi: 10.1186/s13550-015-0145-8. Epub 2015 Nov 17.

5.

Biphasic ⁶⁸Ga-PSMA-HBED-CC-PET/CT in patients with recurrent and high-risk prostate carcinoma.

Sahlmann CO, Meller B, Bouter C, Ritter CO, Ströbel P, Lotz J, Trojan L, Meller J, Hijazi S.

Eur J Nucl Med Mol Imaging. 2016 May;43(5):898-905. doi: 10.1007/s00259-015-3251-y. Epub 2015 Nov 12.

PMID:
26563122
6.

Pelvic lymph node dissection for nodal oligometastatic prostate cancer detected by 68Ga-PSMA-positron emission tomography/computerized tomography.

Hijazi S, Meller B, Leitsmann C, Strauss A, Meller J, Ritter CO, Lotz J, Schildhaus HU, Trojan L, Sahlmann CO.

Prostate. 2015 Dec;75(16):1934-40. doi: 10.1002/pros.23091. Epub 2015 Sep 10.

PMID:
26356236
7.

Transurethral versus suprapubic catheter at robot-assisted radical prostatectomy: a prospective randomized trial with 1-year follow-up.

Martinschek A, Pfalzgraf D, Rafail B, Ritter M, Heinrich E, Trojan L.

World J Urol. 2016 Mar;34(3):407-11. doi: 10.1007/s00345-015-1678-1. Epub 2015 Sep 4.

PMID:
26337521
8.

Prediction of Locally Advanced Urothelial Carcinoma of the Bladder Using Clinical Parameters before Radical Cystectomy--A Prospective Multicenter Study.

Martini T, Aziz A, Roghmann F, Rink M, Chun FK, Fisch M, Trojan L, Hakenberg OW, Zastrow S, Wirth MP, Moersdorf J, Brookman-May S, Stief CG, Haferkamp A, Wagenlehner F, Hohenfellner M, Herrmann E, Lusuardi L, Grimm MO, Müller SC, Roigas J, Bastian PJ, Gierth M, Burger M, Pycha A, Seitz C, May M, Bolenz C.

Urol Int. 2016;96(1):57-64. doi: 10.1159/000433606. Epub 2015 Jul 1.

PMID:
26139354
9.

Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa study.

Kübler H, Scheel B, Gnad-Vogt U, Miller K, Schultze-Seemann W, Vom Dorp F, Parmiani G, Hampel C, Wedel S, Trojan L, Jocham D, Maurer T, Rippin G, Fotin-Mleczek M, von der Mülbe F, Probst J, Hoerr I, Kallen KJ, Lander T, Stenzl A.

J Immunother Cancer. 2015 Jun 16;3:26. doi: 10.1186/s40425-015-0068-y. eCollection 2015.

10.

Increased expression of CYP17A1 indicates an effective targeting of the androgen receptor axis in castration resistant prostate cancer (CRPC).

Bremmer F, Jarry H, Strauß A, Behnes CL, Trojan L, Thelen P.

Springerplus. 2014 Oct 1;3:574. doi: 10.1186/2193-1801-3-574. eCollection 2014.

11.

[Antibiotic resistance in nontyphoidal salmonellae serovars in the Czech Republic].

Zemličková H, Dědičová D, Jakubů V, Mach J, Kolínská R, Malíková E, Urbášková P, Adámková V, Bartoniková N, Bártová M, Bendová E, Bergerová T, Bohunová Z, Čápová E, Dovalová M, Glasnák M, Hanslianová M, Hásková H, Heinigeová B, Hermanová N, Horníková M, Horová B, Chmelařová E, Janečková J, Ježek P, Jindrák V, Kohnová I, Kolářová L, Krčková D, Kůrková V, Linhart P, Machučová M, Miklová J, Niemczyková J, Nyč O, Ochvatová B, Ouertani A, Paterová P, Pokorná Z, Pomykal J, Sekáčová A, Scharfen J, Skačáni H, Steinerová A, Šimečková E, Štolbová M, Tejkalová R, Trojan L, Uhlířová E, Vašková L, Vesela E, Zálabská E, Zamazalová D, Záruba R, Železná J.

Epidemiol Mikrobiol Imunol. 2013 Jul;62(2):43-9. Czech.

PMID:
23964964
12.

Testosterone boosts for treatment of castration resistant prostate cancer: an experimental implementation of intermittent androgen deprivation.

Thelen P, Heinrich E, Bremmer F, Trojan L, Strauss A.

Prostate. 2013 Nov;73(15):1699-709. doi: 10.1002/pros.22711. Epub 2013 Jul 19.

PMID:
23868789
13.

Relaxed imprinting of IGF2 in peripheral blood cells of patients with a history of prostate cancer.

Belharazem D, Kirchner M, Geissler F, Bugert P, Spahn M, Kneitz B, Riedmiller H, Sauer C, Küffer S, Trojan L, Bolenz C, Michel MS, Marx A, Ströbel P.

Endocr Connect. 2012 Oct 24;1(2):87-94. doi: 10.1530/EC-12-0054. Print 2012 Nov 1.

14.

Clinical and pathological nodal staging score for urothelial carcinoma of the bladder: an external validation.

Gierth M, Fritsche HM, Buchner H, May M, Aziz A, Otto W, Bolenz C, Trojan L, Hermann E, Tiemann A, Müller SC, Ellinger J, Brookman-May S, Stief CG, Tilki D, Nuhn P, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Wieland WF, Riedmiller H, Denzinger S, Bastian PJ, Burger M.

World J Urol. 2014 Apr;32(2):365-71. doi: 10.1007/s00345-013-1105-4. Epub 2013 Jun 5.

PMID:
23736527
15.

During twenty years of Cisplatin-based therapy the face of nonseminomatous testicular germ cell tumors is still changing: an evaluation of presentation, management, predictive factors and survival.

Heinzelbecker J, Katzmarzik M, Weiss C, Trojan L, Haecker A.

Int Braz J Urol. 2013 Jan-Feb;39(1):10-21. doi: 10.1590/S1677-5538.IBJU.2013.01.03.

16.

Prediction of outcome in patients with urothelial carcinoma of the bladder following radical cystectomy using artificial neural networks.

Buchner A, May M, Burger M, Bolenz C, Herrmann E, Fritsche HM, Ellinger J, Höfner T, Nuhn P, Gratzke C, Brookman-May S, Melchior S, Peter J, Moritz R, Tilki D, Gilfrich C, Roigas J, Zacharias M, Hohenfellner M, Haferkamp A, Trojan L, Wieland WF, Müller SC, Stief CG, Bastian PJ.

Eur J Surg Oncol. 2013 Apr;39(4):372-9. doi: 10.1016/j.ejso.2013.02.009.

PMID:
23465180
17.

Analysis of sex differences in cancer-specific survival and perioperative mortality following radical cystectomy: results of a large German multicenter study of nearly 2500 patients with urothelial carcinoma of the bladder.

Otto W, May M, Fritsche HM, Dragun D, Aziz A, Gierth M, Trojan L, Herrmann E, Moritz R, Ellinger J, Tilki D, Buchner A, Höfner T, Brookman-May S, Nuhn P, Gilfrich C, Roigas J, Zacharias M, Denzinger S, Hohenfellner M, Haferkamp A, Müller SC, Kocot A, Riedmiller H, Wieland WF, Stief CG, Bastian PJ, Burger M.

Gend Med. 2012 Dec;9(6):481-9. doi: 10.1016/j.genm.2012.11.001.

PMID:
23217567
18.

The role of lymph vessel density and lymphangiogenesis in metastatic tumor spread of nonseminomatous testicular germ cell tumors.

Heinzelbecker J, Gropp T, Weiss C, Huettl K, Stroebel P, Haecker A, Bolenz C, Trojan L.

Urol Oncol. 2014 Feb;32(2):178-85. doi: 10.1016/j.urolonc.2012.08.004. Epub 2012 Nov 7.

PMID:
23141777
19.

Cabazitaxel plus prednisone for metastatic castration-resistant prostate cancer progressing after docetaxel: results from the German compassionate-use programme.

Heidenreich A, Scholz HJ, Rogenhofer S, Arsov C, Retz M, Müller SC, Albers P, Gschwend J, Wirth M, Steiner U, Miller K, Heinrich E, Trojan L, Volkmer B, Honecker F, Bokemeyer C, Keck B, Otremba B, Ecstein-Fraisse E, Pfister D.

Eur Urol. 2013 Jun;63(6):977-82. doi: 10.1016/j.eururo.2012.08.058. Epub 2012 Sep 3.

PMID:
23116658
20.

Leiomyoma of the tunica albuginea, a case report of a rare tumour of the testis and review of the literature.

Bremmer F, Kessel FJ, Behnes CL, Trojan L, Heinrich E.

Diagn Pathol. 2012 Oct 9;7:140. doi: 10.1186/1746-1596-7-140. Review.

Supplemental Content

Loading ...
Support Center